Page last updated: 2024-12-10

thromboxane a2, carbocyclic

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carbocyclic thromboxane A2 : A member of the class of thromboxanes that is thromboxane A2 in which the bridging oxygen has been replaced by a methylene group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5311387
MeSH IDM0082982

Synonyms (17)

Synonym
9alpha,11alpha,11a-dicarba-txa2
(z)-7-[(2s,3r)-3-[(e,3s)-3-hydroxyoct-1-enyl]-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid
gtpl1970
cta-2
thromboxane a2, carbocyclic
carbocyclic thromboxane a2
carbocyclic txa2
cta2
5-heptenoic acid, 7-((2s,3r)-3-((1e,3s)-3-hydroxy-1-octen-1-yl)bicyclo(3.1.1)hept-2-yl)-, (5z)-
0k593aj3ol ,
unii-0k593aj3ol
ZIWNJZLXPXFNGN-JJPTUHNDSA-N
9.alpha.,11.alpha.-methylene-15s-hydroxy-11a-deoxy-11a-methylene-thromba-5z,13e-dien-1-oic acid
Q27075708
SR-01000946877-1
sr-01000946877
AKOS040755332

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The effect of PTA2 on U46619 and CTA2 was dose-dependent over the dosage range of PTA2 tested (1."( U46619 and carbocyclic thromboxane A2-induced increases in tracheal mucous gel layer thickness.
Foxwell, MH; Smith, WL; Yanni, JM, 1988
)
0.27
" Dose-response curves to CPA were shallower and maximal responses were weaker than those produced by the other agonists."( Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett, RJ; Droppleman, DA, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346422Human TP receptor (Prostanoid receptors)1992Japanese journal of pharmacology, Jul, Volume: 59, Issue:3
Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (62.96)18.7374
1990's7 (25.93)18.2507
2000's3 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.63 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]